Capital Expenditures for Cencora (COR)
According to Cencora's latest reported financial statements, the company's current capital expenditures (TTM) is $681.46M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
COR
Currently viewingCapital ExpendituresSwitch metric
Latest period
$681.46M
YoY change
+37.1%
5Y CAGR
+12.6%
Peak year (2025)
$667.98M
Cumulative capital expenditures
$6.89B
CapEx history chart for Cencora (COR) from 1994 to 2025
CapEx history table for Cencora (COR) from 1994 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $667.98M | +37.1% | ||
| 2024 | $487.17M | +6.3% | ||
| 2023 | $458.36M | -7.6% | ||
| 2022 | $496.32M | +13.3% | ||
| 2021 | $438.22M | +18.5% | ||
| 2020 | $369.68M | +19.2% | ||
| 2019 | $310.22M | -7.8% | ||
| 2018 | $336.41M | -27.9% | ||
| 2017 | $466.40M | +0.4% | ||
| 2016 | $464.62M | +100.6% | ||
| 2015 | $231.59M | -12.4% | ||
| 2014 | $264.46M | +30.6% | ||
| 2013 | $202.45M | +23.4% | ||
| 2012 | $164.04M | -2.3% | ||
| 2011 | $167.95M | -9.0% | ||
| 2010 | $184.63M | +26.6% | ||
| 2009 | $145.84M | +6.2% | ||
| 2008 | $137.31M | +16.3% | ||
| 2007 | $118.05M | +4.3% | ||
| 2006 | $113.13M | -44.4% | ||
| 2005 | $203.38M | +7.4% | ||
| 2004 | $189.28M | +109.0% | ||
| 2003 | $90.55M | +41.1% | ||
| 2002 | $64.16M | +174.6% | ||
| 2001 | $23.36M | +40.6% | ||
| 2000 | $16.62M | +5.2% | ||
| 1999 | $15.80M | +51.9% | ||
| 1998 | $10.40M | -34.6% | ||
| 1997 | $15.90M | +1.3% | ||
| 1996 | $15.70M | +14.6% | ||
| 1995 | $13.70M | +61.2% | ||
| 1994 | $8.50M | — |
CapEx values are taken from Cencora's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Cencora (COR) most recent annual capital expenditures stands at $667.98M (2025) – surged 37.1% year-over-year.
Cencora capital expenditures compound annual growth for the 2020–2025 (5 years) window is +12.6%, sustaining 2 straight years of year-over-year growth.
$667.98M stands as the all-time-high annual capital expenditures, posted in 2025, against a low of $8.50M during 1994.
Cencora (COR) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $3.87B.
Cencora Capital Expenditures by Year
Cencora Capital Expenditures 2025: $667.98M
Cencora capital expenditures in 2025 was $667.98M, surged 37.1% from 2024. This figure represents the highest annual value in the available history.
Cencora Capital Expenditures 2024: $487.17M
Cencora capital expenditures in 2024 was $487.17M, grew 6.3% from 2023.
Cencora Capital Expenditures 2023: $458.36M
Cencora capital expenditures in 2023 was $458.36M, declined 7.6% below 2022.
Cencora Capital Expenditures 2022: $496.32M
Cencora capital expenditures in 2022 was $496.32M, grew 13.3% from 2021.
Cencora Capital Expenditures 2021: $438.22M
Cencora capital expenditures in 2021 was $438.22M.
See more financial history for Cencora (COR).
Sector peers — CapEx
Companies in the same sector as Cencora, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is Cencora's capital expenditures?
- Latest reported capital expenditures for Cencora (COR) is $681.46M (period ending December 31, 2025).
How has Cencora capital expenditures changed year-over-year?
- Cencora (COR) capital expenditures changed +37.1% year-over-year on the latest annual filing.
What is the long-term growth rate of Cencora capital expenditures?
- Cencora (COR) capital expenditures compound annual growth rate is +12.6% over the most recent 5 years available.
When did Cencora capital expenditures hit its highest annual value?
- Cencora capital expenditures reached its highest annual value of $667.98M in 2025.
What was Cencora capital expenditures in 2024?
- Cencora (COR) capital expenditures in 2024 was $487.17M.
What was Cencora capital expenditures in 2025?
- Cencora (COR) capital expenditures in 2025 was $667.98M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
COR Overview
Company profile, financial tools, and key metrics
COR Revenue Counter
Earns $10,330 every second. See per minute, hour, and day.
COR Earnings Counter
Earns $51.54 per second net profit. See per minute, hour, and day.
COR Economic Scale
Exceeds Portugal's GDP. Compare with world economies.
COR What If Invested
What if you had invested $1,000? See historical returns from any date.
COR How It Makes Money
Discover visual breakdown of $325.78B in revenue — where it comes from and where it goes.
COR Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
COR Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
COR Daily Price Character
Steady · 51.0% historical win rate (green days). Streaks & record days.
COR Buybacks
0.08% TTM buyback yield. Shareholder yield & SBC comparison.
COR Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
COR Dividend Profile
Yield: 0.74%. Safety: 6/8. See full history.
COR Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
COR Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.